• U. Müller-Werdan
  • M. Buerke
  • A. Christoph
  • R.R. Flieger
  • H. Loppnow
  • R. Prondzinsky
  • S. Reith
  • H. Schmidt
  • K. Werdan


  1. Abella BS, Becker LB (2002) Ischemia-reperfusion and acute apoptotic cell death. In: Vincent JL (ed) 2002 Yearbook of intensive care and emergency medicine. Springer, Berlin Heidelberg New York, pp 3–11Google Scholar
  2. Adams HA, Baumann G, Gänsslen A et al. und die IAG Schock (2001) Die Definitionen der Schockformen. Intensivmed 38: 541–553Google Scholar
  3. AHA — ECC (2000) Guidelines 2000 for cardiopulmonary resuscitation and emergency cardiovascular care — a consensus on science. Circulation 102(Suppl 8): I1–I384Google Scholar
  4. Ahnefeld FW, Barth J, Dick W et al. (1994) Akuttherapie anaphylaktoider Reaktionen. Anästhesist 43: 211–222Google Scholar
  5. Alpert JS, Becker RC (1993) Cardiogenic shock: elements of etiology, diagnosis, and therapy. Clin Cardiol 16(3): 182–190PubMedGoogle Scholar
  6. American Thoracic Society, European Society of Intensive Care Medicine, Societé de Reanimation Langue Francaise (1999) International consensus conferences in intensive care medicine. Ventilator-associated lung injury in ARDS. Intensive Care Med 25: 1444–1452Google Scholar
  7. Andersen HR, Nielsen TT, Rasmussen K et al. (2003) A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction. N Engl J Med 349: 733–742PubMedCrossRefGoogle Scholar
  8. Annane D, Cavaillon JM (2003) Corticosteroids in sepsis: from bench to bedside? Shock 20: 197–207PubMedGoogle Scholar
  9. Annane D, Sébille V, Charpentier et al. (2002) Effect of a treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 288: 862–871PubMedCrossRefGoogle Scholar
  10. Antoniucci D, Valenti R, Santoro GM et al. (1998) Systematic direct angioplasty and stent-supported direct angioplasty therapy for cardiogenic shock complicating acute myocardial infarction: In-hospital and long-term survival. J Am Coll Cardiol 31: 294–300PubMedGoogle Scholar
  11. Antoniucci D, Valenti R, Migliorini A et al. (2002) Abciximab therapy improves survival in patients with acute myocardial infarction complicated by early cardiogenic shock undergoing coronary artery stent implantation. Am J Cardiol 90(4): 353–357PubMedCrossRefGoogle Scholar
  12. Antoniucci D, Valenti R, Migliorini A et al. (2003) Comparison of impact of emergency percutaneous revascularization on outcome of patients >or =75 to those <75 years of age with acute myocardial infarction complicated by cardiogenic shock. Am J Cardiol 91(12): 1458–1461PubMedCrossRefGoogle Scholar
  13. Artigas A, Bernard GR, Carlet J et al. and the Consensus Committee (1998) The American-European Consensus Conference of ARDS, Part 2. Am J Respir Crit Care Med 157: 1332–1347PubMedGoogle Scholar
  14. Asfar P, Pierrot M, Veal V et al. (2003) Low-dose terlipressin improves systemic and splanchnic hemodynamics in fluid-challenged endotoxic rats. Crit Care Med 31: 215–220PubMedGoogle Scholar
  15. Austin SM, Barooah B, Kim CS (1984) Reversible acute cardiac injury during cefoxitin-induced anaphylaxis in a patient with normal coronary arteries. Am J Med 77: 729–732PubMedCrossRefGoogle Scholar
  16. Bahrami S, Redl H, Schlag G (1998) Der Darm als Ursache von Sepsis und Multiorganversagen. Wien Klin Wochenschr 110(Suppl 1): 2–10PubMedGoogle Scholar
  17. Ballal RS, Sanyal RS, Nanda NC, Mahan EF III (1993) Usefulness of transesophageal echocardiography in the diagnosis of ventricular septal rupture secondary to acute myocardial infarction. Am J Cardiol 71: 367–370PubMedCrossRefGoogle Scholar
  18. Barron HV, Every NR, Parsons LS et al. (2001) The use of intra-aortic balloon counterpulsation in patients with cardiogenic shock complicating acute myocardial infarction: data from the National Registry of Myocardial Infarction. Am Heart J 141: 933–939PubMedCrossRefGoogle Scholar
  19. Baue AE, Faist E, Fry DE (2000) Multiple organ failure — pathophysiology, prevention and therapy. Springer, Berlin Heidelberg New YorkGoogle Scholar
  20. Behringer W, Kittler H, Sterz F et al. (1998) Cumulative epinephrine dose during cardiopulmonary resuscitation and neurologic outcome. Ann Intern Med 129: 450–456. Editorial (Cummins RO, Hazinski MF) 129:501-502PubMedGoogle Scholar
  21. Beilman GJ, Groehler KE, Lazaron V, Ortner JP (1999) Near-infrared spectroscopy measurement of regional tissue oxyhemoglobin saturation during hemorrhagic shock. Shock 12: 196–200PubMedGoogle Scholar
  22. Beishuizen A, Thijs LG (2003) Endotoxin and the hypothalamo-pituitaryadrenal (HPA) axis. J Endotoxin Res 9: 3–24PubMedCrossRefGoogle Scholar
  23. Bernard SA, Buist M (2003) Induced hypothermia in critical care medicine: A review. Crit Care Med 31: 2041–2051PubMedGoogle Scholar
  24. Bernard GR, Vincent JL, Laterne PF et al. (2001) Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 344: 699–709PubMedCrossRefGoogle Scholar
  25. Bengur AR, Meliones JN (1998) Cardiogenic shock. New Horiz 6(2): 139–149PubMedGoogle Scholar
  26. Bernard SA, Gray TW, Buist MD et al. (2002) Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia. N Engl J Med 346: 557–5634PubMedCrossRefGoogle Scholar
  27. Bertolini G, Iapichino G, Radrizzani D (2003) Early enteral immunonutrition in patients with severe sepsis — Results of an interim analysis of a randomized multicentre clinical trial. Intensive Care Med 29: 834–840PubMedCrossRefGoogle Scholar
  28. Birnbaum Y, Fishbein MC, Blanche C, Siegel RJ (2002) Ventricular septal rupture after acute myocardial infarction. N Engl J Med 347: 1426–1432PubMedCrossRefGoogle Scholar
  29. Blumberg N, Heal JM (1998) Blood transfusion immunomodulation — the silent epidemic. Arch Pathol Lab Med 122: 117–119PubMedGoogle Scholar
  30. Bodmann KF, Vogel F (2001) Antimikrobielle Therapie der Sepsis — Empfehlungen einer Arbeitsgruppe der Paul-Ehrlich-Gesellschaft für Chemotherapie e.V. Chemotherapie J 10: 43–55Google Scholar
  31. Boekstegers P, Weidenhöfer S, Kapsner T, Werdan K (1994) Skeletal muscle partial pressure of oxygen in patients with sepsis. Crit Care Med 22: 640–650PubMedGoogle Scholar
  32. Böhm D (2002) Anwendung pharmakokinetischer Prinzipien bei kritisch Kranken. In: Böhm D, Werdan K (Hrsg) Themenheft: Rationale Arzneimitteltherapie bei kritisch Kranken. Intensiv Notfallbehandl 27: 156–164Google Scholar
  33. Böhm D, Werdan K (2002) Editorial. Themenheft: Rationale Arzneimitteltherapie bei kritisch Kranken. Intensiv Notfallbehandl 27: 153–155Google Scholar
  34. Böker KHW, Manns MP (1998) Akutes Leberversagen. Internist 39: 442–452PubMedGoogle Scholar
  35. Boldt J (2003) Verursacht Hydroxethylstärke (HES) ein Nierenversagen? Intensiv News 7: 17–19Google Scholar
  36. Bond RF (1993) Peripheral macro-and microcirculation. In: Schlag G, Redl H (eds) Pathophysiology of shock, sepsis and organ failure. Springer, Berlin Heidelberg New York, pp 893–907Google Scholar
  37. Bonnefoy E, Lapostolle F, Leizorovicz A et al. (2002) Primary angioplasty versus prehospital fibrinolysis in acute myocardial infarction: a randomised study. Lancet 360: 825–829PubMedCrossRefGoogle Scholar
  38. Bonz AW, Lengenfelder B, Strotmann J et al. (2002) Effect of additional temporary glycoprotein IIb/IIIa receptor inhibition on troponin release in elective percutaneous coronary interventions after pretreatment with aspirin and clopidogrel (TOPSTAR trial). J Am Coll Cardiol 40: 662–668PubMedCrossRefGoogle Scholar
  39. Booth BH, Patterson R (1970) Electrocardiographic changes in human anaphylaxis. JAMA 211: 627PubMedCrossRefGoogle Scholar
  40. Bowers TR, O’Neill WW, Grines C et al. (1998) Effect of reperfusion on biventricular function and survival after right ventricular infarction. N Engl J Med 338: 933–940PubMedCrossRefGoogle Scholar
  41. Brealey D, Brand M, Hargreaves I (2002) Association between mitochondrial dysfunction and severity and outcome of septic shock. lancet 360: 219–223PubMedCrossRefGoogle Scholar
  42. Briegel J (2003) Septische Enzephalopathie — häufig verkannt und unterschätzt. Anaesthesist 52: 293PubMedCrossRefGoogle Scholar
  43. Briegel J, Forst H, Haller M et al. (1999) Stress doses of hydrocortisone reverse hyperdynamic septic shock: a prospective, randomized, double-blind, single-center study. Crit Care Med 27: 723–732PubMedGoogle Scholar
  44. Brodie BR, Stuckey TD, Hansen C et al. (1999) Intra-aortic ballon counterpulsation before primary percutaneous transluminal coronary angioplasty reduces catheterization laboratory events in high-risk patients with acute myocardial infarction; Am J Cardiol 84: 18–23PubMedCrossRefGoogle Scholar
  45. Bruch C, Comber M, Schmermund A et al. (2003) Diagnostic usefulness and impact on management of transesophageal echocardiography in surgical intensive care units. Am J Cardiol 91: 510–513PubMedCrossRefGoogle Scholar
  46. Bur A, Bayegan K, Holzer M et al. (2002) Intra-aortic balloon counterpulsation in the emergency department: a 7-year review and analysis of predictors of survival. Resuscitation 53: 259–264PubMedCrossRefGoogle Scholar
  47. Burchardi H, Briegel J, Eckart J et al. (2000) Expertenforum: Hämodynamisch aktive Substanzen in der Intensivmedizin. Anästhesiol Intensivmed 41: 560–631Google Scholar
  48. Califf RM, Bengtson JR (1994) Cardiogenic shock. N Engl J Med 330: 1724–1730PubMedCrossRefGoogle Scholar
  49. Calvo FE, Figueras J, Cortadellas J, Soler JS (1997) Severe mitral regurgitation complicating acute myocardial infarction. Clinical and angiographic differences between patients with and without papillary muscle rupture. Eur Heart J 18: 1606–1610PubMedGoogle Scholar
  50. Carlson RW, Schaeffer RC, Puri VK et al. (1981) Hypovolemia and permeability pulmonary edema associated with anaphylaxis. Crit Care Med 9: 883PubMedGoogle Scholar
  51. Chan AW, Chew DP, Bhatt DL et al. (2002) Long-term mortality benefit with the combination of stents and abciximab for cardiogenic shock complicating acute myocardial infarction. Am J Cardiol 89: 132–136PubMedCrossRefGoogle Scholar
  52. Cheifetz IM, Craig DM, Kern FH et al. (1996) Nitric oxide improves transpulmonary vascular mechanics but does not change intrinsic right ventricular contractility in an acute respiratory distress syndrome model with permissive hypercapnia. Crit Care Med 24: 1554–1561PubMedGoogle Scholar
  53. Choi PT-L, Yip G, Quinonez LG, Cook DJ (1999) Crystalloids vs. colloids in fluid resuscitation: a systematic review. Crit Care Med 27: 200–210PubMedGoogle Scholar
  54. Christ F, Lackner CK (2004) Präklinische Versorgung des Patienten im Schock. Internist 45: 267–276PubMedGoogle Scholar
  55. Ciurana CLF, Hack CE (2002) Molecular Mechanisms of complement Activation during Ischemia and Reperfusion. In: Vincent JL (ed) 2002 Yearbook of intensive care and emergency medicine. Springer, Berlin Heidelberg New York, pp 39–49Google Scholar
  56. Claussen MS, Landercasper J, Cogbill TH (1992) Acute adrenal insufficiency presenting as shock after trauma and surgery: three cases and review of the literature. J Trauma 32: 94–100PubMedGoogle Scholar
  57. Cobas Meyer M, Depka M von (2003) Neue gerinnungsphysiologische Erkenntnisse in der schweren Sepsis: Sind diese in der Diagnostik nutzbar? In: Huhle G (Hrsg) Themenheft: Sepsis und Gerinnung. Intensiv Notfallbehandl 28: 37–43Google Scholar
  58. Cohen J (2000) The detection and interpretation of endotoxaemia (2000) Intensive Care Med 26:S52-S56Google Scholar
  59. Cohen M, Urban P, Christenson JT et al. (2003) Intra-aortic ballon counterpulsation in US and Non-US-Centers: Results of Benchmark-Registry; European Heart Journal 24: 1763–1770PubMedCrossRefGoogle Scholar
  60. Cohen TJ, Goldner BG, Maccaro PC et al. (1993) A comparison of active compression-decompression cardiopulmonary resuscitation with standard cardiopulmonary resuscitation for cardiac arrests occurring in the hospital. N Engl J Med 329: 1918–1921PubMedGoogle Scholar
  61. Cole L, Bellomo R, Journois D et al. (2001) High-volume haemofiltration in human septic shock. Intensive Care Med 27: 978–986PubMedGoogle Scholar
  62. Cooper DJ, Walley KR, Wiggs BR, Russell JA (1990) Bicarbonate does not improve hemodynamics in critically ill patients who have lactic acidosis: a prospective, controlled clinical study. Ann Intern Med 112: 492–498PubMedGoogle Scholar
  63. Corwin HL, Gettinger A, Pearl RG (2002) Efficacy of recombinant human erythropoietin in critically ill patients: a randomized controlled trial. JAMA 288: 2827–2835PubMedCrossRefGoogle Scholar
  64. Cotter G, Moshkovitz Y, Kaluski E et al. (2003a) The role of cardiac power and systemic vascular resistance in the pathopyhsiology and diagnosis of patients with acute congestive heart failure. Eur J Heart Fail 5: 443–451PubMedGoogle Scholar
  65. Cotter G, Williams SG, Vered Z, Tan LB (2003b) Role of cardiac power in heart failure. Current Opinion Cardiology 18: 215–222Google Scholar
  66. Cotter G, Kaluski E, Milo O et al. (2003c) LINCS: L-NAME (a NO synthase inhibitor) in the treatment of refractory cardiogenic shock: a prospective randomized study. Eur Heart J 24: 1287–1295PubMedGoogle Scholar
  67. Cox FF, Morshuis WJ, Plokker HWT et al. (1996) Early mortality after surgical repair of postinfarction ventricular septal rupture: importance of rupture location. Ann Thorac Surg 61: 1752–1758PubMedCrossRefGoogle Scholar
  68. Cuffe MS, Califf RM, Adams KF et al. (2002) For the Outcome of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF) Investigators. Short-term intravenous milrinone for acute exacerbation of chronic heart failure — a randomized controlled trial. JAMA 287: 1541–1547PubMedCrossRefGoogle Scholar
  69. Cummings RG, Califf R, Jones RN et al. (1997) Correlates of survival in patients with postinfarction ventricular septal defect. Ann Thorac Surg 63: 1508–1509CrossRefGoogle Scholar
  70. Czock D, Keller F (2002) SIRS und Sepsis — akutes Nierenversagen — Nierenersatzverfahren und Dosisanpassung von Medikamenten. In: Böhm D, Werdan K (Hrsg) Themenheft: Rationale Arzneimitteltherapie bei kritisch Kranken. Intensiv Notfallbehandl 27: 172–183Google Scholar
  71. De Backer D (2003) Lactic acidosis. Intensive Care Med 29: 699–702PubMedGoogle Scholar
  72. De Backer D, Creteur J, Preiser JC et al. (2002) Microvascular blood flow is altered in patients with sepsis. Am J Respir Crit Care Med 166: 98–104PubMedGoogle Scholar
  73. Dellinger RP (2003) Cardiovascular management of septic shock. Crit Care Med 31: 946–955PubMedGoogle Scholar
  74. Dellinger RP, Carlet JM, Masur H et al. (2004) For the Surviving Sepsis Campaign Management Guidelines Committee: Surviving Sepsis Campaign Guidelines for management of severe sepsis and septic shock. Crit Care Med 32: 858–873; Intensive Care Med 30: 536-555PubMedGoogle Scholar
  75. Dempfle CE (2003) Veränderungen der Hämostase in der Sepsis: Ursachen oder Folgen? In: Huhle G (Hrsg) Themenheft: Sepsis und Gerinnung Intensiv Notfallbehandl 28: 26–36Google Scholar
  76. De Vega JMA, Diaz J, Serrano E, Carbonelli LF (2002) Oxidative stress in critically ill patients with systemic inflammatory response syndrome. Crit Care Med 30: 1782–1786Google Scholar
  77. DeWerra I, Jaccard C, Betz Corradin S et al. (1997) Cytokines, nitrite/nitrate, soluble tumor factor receptors, and procalcitonin concentations: Comparison in patients with septic shock, cardiogenic shock, and bacterial pneumonia. Crit Care Med 25: 607–613Google Scholar
  78. Dhainaut JF, Dall’Ava J, Mira JP (1993) Coronary hemodynamics and myocardial metabolism in sepsis and septic shock. In: Schlag G, Redl H (eds) Pathophysiology of shock, sepsis and organ failure. Springer, Berlin Heidelberg New York, pp 882–892Google Scholar
  79. Dieterich HJ (2001) Kristalloide versus Kolloide — A never ending story? Anaesthesist 50: 432–435PubMedGoogle Scholar
  80. Donnino M, Nguyen B, Rivers E (2002) Hemodynamic comparison of early and late phase severe sepsis and septic shock. Chest 122:5SGoogle Scholar
  81. Dörges V, Wenzel V (2001) Ventilation zur kardiopulmonalen Reanimation. Intensivmed 38: 576–589Google Scholar
  82. Dorian P, Cass D, Schwartz B (2002) Amiodarone as compared with lidocaine for shock-resistant ventricular fibrillation. N Engl J Med 346: 884–890PubMedCrossRefGoogle Scholar
  83. Douzinas EE, Pitaridis MT, Louris G et al. (2000) Prevention of infection in multiple trauma patients by high-dose intravenous immunoglobulins. Crit Care Med 28: 8–15PubMedGoogle Scholar
  84. Dünser MW, Mayr AJ, Ulmer H et al. (2001) The effects of vasopressin on systemic hemodynamics in catecholamine-resistant septic and post-cardiotomy shock: a retrospective analysis. Anesth Analg 93: 7–13PubMedGoogle Scholar
  85. Dünser MW, Mayr AJ, Ulmer H et al. (2003) Arginine Vasopressin in advanced vasodilatory shock. Circulation 107: 2313–2319PubMedGoogle Scholar
  86. Dzavik V, Sleeper LA, Cocke TP et al. (2003) Early revascularization is associated with improved survival in elderly patients with acute myocardial infarction complicated by cardiogenic shock: a report from the SHOCK Trial Registry. Eur Heart J 24: 828–837PubMedCrossRefGoogle Scholar
  87. Eckardt KU (2003) Das Ende der Blutkonserven? Intensiv-News 7: 24–25Google Scholar
  88. Eggers V, Schilling A, Kox WJ, Spies C (2003) Septische Enzephalopathie — Differentialdiagnose und therapeutische Einflußmöglichkeiten. Anaesthesist 52: 294–303PubMedCrossRefGoogle Scholar
  89. Eisenberg MS, Mengert TJ (2001) Cardiac resuscitation. N Engl J Med 344: 1304–1313PubMedCrossRefGoogle Scholar
  90. Eisenberg PR, Jaffe AS, Schuster DP (1984) Clinical evaluation compared to pulmonary artery catheterization in the hemodynamic assessment of critically ill patients. Crit Care Med 12: 549–553PubMedGoogle Scholar
  91. Elsakka N, Galley HF, Webster NR (2001) Mitochondrial antioxidant activity and disease processes. In: Vincent JL (ed) Yearbook of intensive care and emergency medicine. Springer, Berlin Heidelberg New York, pp 278–283Google Scholar
  92. Emmenegger V, Frey U, Reimers A et al. (2001) Hyperferritinemia as indicator of intravenous immunoglobulin treatment in reactive macrophage acitvation syndromes. Am J Hematology 68: 4–10CrossRefGoogle Scholar
  93. Engelmann L (2000a) Update-Thema: Akutes Lungenversagen — ARDS. Intensiv Notfallbehandl 25: 87–96Google Scholar
  94. Engelmann L (2000b) Das Open-Lung-Konzept. Internist 41: 985–994PubMedCrossRefGoogle Scholar
  95. Fernandes CJ Jr, Akamine N, De Marco FVC (2001) Red blood cell transfusion does not increase oxygen consumption in criticaly ill septic patients. Crit Care Med 5: 362–367Google Scholar
  96. Ferrari M, Figulla HR (2005) Mechanische Herz-Kreislaufunterstützung in der Kardiologie. Dtsch Med Wochenschr (im Druck)Google Scholar
  97. Ferrari M, Wittmann G, Neumann S et al. (1998) Die perkutan implantierbare Herz-Lungen-Maschine erweitert die therapeutischen und diagnostischen Möglichkeiten bei therapierefraktärem Kreislaufstillstand — Fallpräsentation und Übersicht. Intensivmed 35: 56–61CrossRefGoogle Scholar
  98. Figueras J, Cortadellas J, Domingo E, Soler-Soler J (2001) Survival following self-limited left ventricular free wall rupture dring myocardial infarction. Management differences between patients with or without pseudoaneurysm formation. Int J Cardiol 79: 103–111. Letter to the Editor: Beranek JT (2002) Pathogenesis of postinfarction free wall rupture. 84:91-92PubMedCrossRefGoogle Scholar
  99. Fink MP (2003) Ethyl pyruvate: a novel anti-inflammatory agent. In: Vincent JL (ed) Yearbook of intensive care and emergency medicine. Springer, Berlin Heidelberg New York, pp 604–614Google Scholar
  100. Finney SJ, Evans TW, Burke-Gaffney A (2002) Cell adhesion molecules and leucocyte trafficking in sepsis. In: Vincent JL (ed) Yearbook of intensive care and emergency medicine. Springer, Berlin Heidelberg New York, pp 23–38Google Scholar
  101. Fletcher SN, Kennedy DD, Ghosh IR et al. (2003) Hinds: persistent neuromuscular and neurophysiologic abnormalities in long-term survivors of prolonged critical illness. Crit Care Med 31: 1012–1016PubMedGoogle Scholar
  102. Flieger RRF, Werdan K (2004) Pulmonalarterienkatheter-Monitoring bei kritisch Kranken — Eine Momentaufnahme 2004. Intensiv-News 8: 9–13Google Scholar
  103. Follath F, Cleland JGF, Just H (2002) Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial. Lancet 360: 196–202PubMedCrossRefGoogle Scholar
  104. Formica M, Olivieri C, Livigni S (2003) Hemodynamic response to coupled plasmafi ltration-adsorption in human septic shock. Intensive Care Med 29: 703–708PubMedGoogle Scholar
  105. Freeman BD, Parrillo JE, Natanson C (2001) Septic shock and multiple organ failure. In: Parrillo JE, Dellinger RP (eds) Critical care medicine principles of diagnosis and management in the adult, 2nd edn. Mosby, St. Louis, MO, pp 437–452Google Scholar
  106. Gawaz M, Fateh-Moghadam S, Pilz G et al. (1995) Severity of multiple organ failure (MOF) but not of sepsis correlates with irreversible platelet degranulation. Infection 23: 16–23PubMedCrossRefGoogle Scholar
  107. Gellerich FN, Trumbeckaite S, Hertel K et al. (1999) Impaired energy metabolism in hearts of septic baboons: diminished activities of complex I and complex II of the mitochondrial respiratory chain. Shock 11: 336–341PubMedGoogle Scholar
  108. Ginz HF, Gottschall V, Schwarzkopf G, Walter K (1998) Exzessive Gewebespeicherung von Kolloiden im retikuloendothelialen System. Anaesthesist 47: 330–334PubMedCrossRefGoogle Scholar
  109. Giri S, Mitchel J, Azar RR et al. (2002) Results of primary percutaneous transluminal coronary angioplasty plus abciximab with or without stenting for acute myocardial infarction complicated by cardiogenic shock. Am J Cardiol 89: 126–131PubMedCrossRefGoogle Scholar
  110. Godin PJ, Buchman TG (1996) Uncoupling of biological oscillators: A complementary hypothesis concerning the pathogenesis of multiple organ dysfunction syndrome. Crit Care Med 24: 1107–1116PubMedGoogle Scholar
  111. Goldberg RJ, Samad NA, Yarzebski J et al. (1999) Temporal trends in cardiogenic shock complicating acute myocardial infarction. N Engl J Med 340: 1162–1168PubMedCrossRefGoogle Scholar
  112. Graf J, Graf C, Janssens U (2003) Nutzen intensivmedizinischer Scoring Systeme zur Beurteilung der Ergebnisqualität, Prognoseabschätzung und Kostenanalyse internistischer Intensivpatienten. Intensiv Notfallbehandl 28: 158–164Google Scholar
  113. Granger CB, Mahaffey K, Weaver WD et al. (2003) Pexelizumab an anti-C5 complement antibody, as adjunctive therapy to primary percutaneous coronary intervention in acute myocardial infarction. Circulation 108: 1184–1190PubMedCrossRefGoogle Scholar
  114. Green R, Scott LK, Minagar A, Conrad S (2004) Sepsis associated encephalopathy (SAE): a review. Frontiers Bioscience 9: 1637–1641Google Scholar
  115. Gregg W, Stone E, Ohman M et al. (2003) Contemporary utilization and outcomes of intra-aortic ballon counterpulsation in acute myocardial infarction. J Am Coll Cardiol 41: 1940–1945Google Scholar
  116. Groeneveld ABJ (2001) Hypovolemic shock. In: Parrillo JE, Dellinger RP (eds) Critical care medicine — principles of diagnosis and management in the adult, 2nd edn. Mosby, St. Louis, MO, pp 465–500Google Scholar
  117. Groner W, Winkelman JW, Harris AG et al. (1999) Orthogonal polarization spectral imaging: a new method for study of the microcirculation. Nature Medicine 5: 1209–1213PubMedGoogle Scholar
  118. Group THaCaS (2002) Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest. N Engl J Med 346: 549Google Scholar
  119. Gueugniaud PY, Mols P, Goldstein P et al. for the European Epinephrine Study Group (1998) A comparison of repeated high doses and repeated standard doses of epinephrine for cardiac arrest outside the hospital. N Engl J Med 339: 1595–601. 340:1763-1765 (Correspondence 1999)PubMedCrossRefGoogle Scholar
  120. Guyton K, Bond R, Romeo C et al. (1999) Endotoxin-induced cross-tolerance to Gram-positive sepsis. J Endotoxin Res 5: 119–126CrossRefGoogle Scholar
  121. Hallstrom A, Cobb L, Johnson E, Copass M (2000) Cardiopulmonary resuscitation by chest compression alone or with mouth-to-mouth ventilation. N Engl J Med 342: 1546–1553PubMedCrossRefGoogle Scholar
  122. Hallström S, Koidl B, Müller U et al. (1993) Cardiodepressant factors. In: Schlag G, Redl H (eds) Pathophysiology of shock, sepsis and organ failure. Springer, Berlin Heidelberg New York, pp 200–214Google Scholar
  123. Hamberger B, Fredholm BB, Farnebo LO (1980) Anaphylaxis and plasma catecholamines. Life Sci 26: 1465–1471PubMedCrossRefGoogle Scholar
  124. Hanashiro PK, Weil MH (1967) Anaphylactic shock in man: report of two cases with detailed hemodynamic and metabolic studies. Arch Intern Med 119: 129–140PubMedCrossRefGoogle Scholar
  125. Hamm CW (2004) Herausgegeben vom Vorstand der Deutschen Gesellschaft für Kardiologie — Herz-und Kreislaufforschung. Bearbeitet im Auftrag der Kommission für Klinische Kardiologie Leitlinien: Akutes Koronarsyndrom (ACS) Teil 1: ACS ohne persistierende ST-Hebung; Teil 2: Akutes Koronarsyndrom mit ST-Hebung (Myokardinfarkt). Z Kardiol 93: 72–90PubMedGoogle Scholar
  126. Hasdai D, Topol EJ, Califf RM et al. (2000a) Cardiogenic shock complicating acute coronary syndromes. Lancet 356: 749–756PubMedCrossRefGoogle Scholar
  127. Hasdai D, Califf RM, Thompson TD et al. (2000b) Predictors of cardiogenic shock after thrombolytic therapy for acute myocardial infarction. J Am Coll Cardiol 35: 136–143PubMedGoogle Scholar
  128. Hasdai D, Harrington RA, Hochman JS et al. (2000c) Platelet glycoprotein IIb/IIIa blockade and outcome of cardiogenic shock complicating acute coronary syndromes without persistent ST-segment elevation. J Am Coll Cardiol 36: 685–692PubMedCrossRefGoogle Scholar
  129. Haupt MT (2001) Anaphylaxis and anaphylactic Shock. In: Parrillo JE, Dellinger RP (eds) Critical care medicine — principles of diagnosis and management in the adult, 2nd edn. Mosby, St. Louis, MO, pp 513-526Google Scholar
  130. Hausmann H, Potapov EV, Koster A et al. (2002) Prognosis after the implantation of an intra-aortic balloon pump in cardiac surgery calculated with a new score. Circulation 106(Suppl I): I203–I206PubMedGoogle Scholar
  131. Hayes MA, Timmins AC, Yau EHS (1994) Elevation of systemic oxygen delivery in the treatment of critically ill patients. N Engl J Med 330: 1717–1722PubMedCrossRefGoogle Scholar
  132. Hebert P, Wells G, Blajchman MA et al. (1999) A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. N Engl J Med 340: 409–417PubMedCrossRefGoogle Scholar
  133. Heinroth KM, Kuhn C, Stache N et al. (1999) Eingeschränkte Herzfrequenzvariabilität bei Patienten mit septischem und nicht-septischem Multiorgan-Dysfunktions-Syndrom. Intensivmed 36: 436–445CrossRefGoogle Scholar
  134. Held AC, Cole PL, Lipton B et al. (1988) Rupture of the interventricular septum complicating acute myocardial infarction: a multicenter analysis of clinical findings and outcome. Am Heart J 116: 1330–1336PubMedCrossRefGoogle Scholar
  135. Hermann HB, Pieske B, Schwarzmüller E et al. (1999) Hemodynamic effects of intracoronary pyruvate in patients with congestive heart failure: An open study. Lancet 353: 1321–1323PubMedCrossRefGoogle Scholar
  136. Herridge MS, Cheung AM, Tansey CM et al. for the Canadian Critical Care Trials Group (2003) One-year outcomes in survivors of the acute respiratory distress syndrome. N Engl J Med 348: 683–693PubMedCrossRefGoogle Scholar
  137. Heyland DK, Samis A (2003) Does immunonutrition in patients with sepsis do more harm than good? Intensive Care Med 29: 669–671PubMedGoogle Scholar
  138. Hochman JS, Sleeper LA, Webb JG et al. for the SHOCK Investigators (1999) Early revascularization in acute myocardial infarctions complicated by cardiogenic shock. N Engl J Med 341: 625–634PubMedGoogle Scholar
  139. Hochman JS, Buller CE, Sleeper LA et al. (2000) Cardiogenic shock complicating acute myocardial infarction-etiologies, management and outcome: a report from the SHOCK Trial Registry. Should we emergently revascularize occluded coronaries for cardiogenic shock? J Am Coll Cardiol 36: 1063–1070PubMedCrossRefGoogle Scholar
  140. Hochman JS, Talley JD, Webb JC et al. (1997) Ventricular septal rupture causing cardiogenic shock: clinical profile, timing and outcome. Circulation 96:I-749Google Scholar
  141. Hoffmann B, Welte T (2002) Der akute Myokardinfarkt — ein unterschätzter und oft unerkannter Mortalitätsfaktor bei septischen Patienten? Intensivmed 39677–681Google Scholar
  142. Hoffmann JN, Hartl W, Deppisch R et al. (1996) Effect of hemofiltration on hemodynamics and systemic concentrations of anaphylatoxins and cytokines in human sepsis. Intensive Care Med 22: 1360–1367PubMedGoogle Scholar
  143. Hoffmann JN, Werdan K, Hartl WH et al. (1999) Hemofiltrate from patients with severe sepsis and depressed left ventricular contractility contains cardiotoxic compounds. Shock 12/3: 174–180Google Scholar
  144. Hollenberg SM (2001) Cardiogenic shock. Crit Care Clin 17(2): 391–410PubMedCrossRefGoogle Scholar
  145. Hollenberg SM (2003) Cardiogenic shock: overview. Intensivmed 40: 269–275CrossRefGoogle Scholar
  146. Hollenberg SM, Kavinsky CJ, Parrillo JE (1999) Cardiogenic shock. Ann Intern Med 131(1): 47–59PubMedGoogle Scholar
  147. Holtz J (2000) Physiologische Wirkprinzipien. In: Burchardi H, Briegel J, Eckart J et al. (Hrsg) Expertenforum: Hämodynamisch aktive Substanzen in der Intensivmedizin. Anästhesiol Intensivmed 41: 562–568Google Scholar
  148. Hotchkiss RS, Swanson PE, Freeman BD et al. (1999) Apoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction. Crit Care Med 27: 1230–1251PubMedGoogle Scholar
  149. Hudson LD, Lee CM (2003) Neuromuscular sequelae of critical illness. N Engl J Med 348: 745–747PubMedGoogle Scholar
  150. Huhle G (2003) Editorial. Themenheft: Sepsis und Gerinnung. Intensiv Notfallbehandl 28: 1–3Google Scholar
  151. Hund E (2001) Neurological complications of sepsis: critical illness polyneuropathy and myopathy. J Neurol 248: 929–934PubMedCrossRefGoogle Scholar
  152. Hund E, Abel R (2002) Spinaler Schock. Intensiv Notfallbehandl 27: 131–136Google Scholar
  153. Ince C (2002) The microcirculation unveiled. Am J Resp Crit Caare Med 166: 1–4Google Scholar
  154. Intravenous Immunoglobulin Study Group (1992) Prophylactic intravenous administration of standard immune globulin as compared with core-lipopolysaccharide immune globulin in patients at high risk of postsurgical infection. N Engl J Med 327: 234–240Google Scholar
  155. Jacobs AK, French JK, Col J et al. for the SHOCK Investigators (2000) Cardiogenic shock with non-ST-segment elevation myocardial in-farction: a report from the SHOCK Trial Registry. J Am Coll Cardiol 36: 1091–1096PubMedCrossRefGoogle Scholar
  156. Jacobs AK Leopold JA, Bates E et al. (2003) Cardiogenic shock caused by right ventricular infarction. J Am Coll Cardiol 41: 1273–1279PubMedCrossRefGoogle Scholar
  157. Jakob SM, Takala J (2000) Splanchnic hemodynamics in critical illness. current Opinion in Critical Care 6: 123–129Google Scholar
  158. Jakob SM, Tenhunen JJ, Heino A et al. (2002) Splanchnic vasoregulation during mesenteric ischemia and reperfusion in pigs. Shock 18: 142–147PubMedGoogle Scholar
  159. Janssens (2001) Monitoring des herzkranken Intensivpatienten. Intensivmed 38: 232–250CrossRefGoogle Scholar
  160. Janssens U, Graf C, Graf J, Hanrath P (2002) Mortality Probability Model (MPM II0-72) bei Patienten einer kardiologischen Intensivstation. Intensivmed 39: 26–37CrossRefGoogle Scholar
  161. Janssens U, Graf J (2004) Was ist »Schock«? Internist 45: 258–266PubMedCrossRefGoogle Scholar
  162. Kato S, Morimoto S-I, Hiramitsu S et al. (1999) Use of percutaneous cardiopulmonary support of patients with fulminant myocarditis and cardiogenic shock for improving prognosis. Am J Cardiol 83: 623–625PubMedCrossRefGoogle Scholar
  163. Kellum JA (2003) Hemoadsorption therapy for sepsis syndromes. Crit Care Med 31: 323–324PubMedGoogle Scholar
  164. Kierdorf H (2001) Akutes Nierenversagen. Intensiv-und Notfallbehandlung, Themenheft 1 und 2/2001Google Scholar
  165. Kilger E, Weis F, Briegel J et al. (2003) Stress doses of hydrocortisone reduce severe systemic inflammatory response syndrome and improve early outcome in a risk group of patients after cardiac surgery. Crit Care Med 31: 1068–1074PubMedGoogle Scholar
  166. Killen DA, Piehler JM, Borkon AM et al. (1997) Early repair of postinfarction ventricular septal rupture. Ann Thorac Surg 63: 138–142PubMedGoogle Scholar
  167. Kivikko M, Lehtonen L, Coloucci WS et al. (2003) Sustained hemodynamic effects of intravenous levosimendan. Circulation 107: 81–86PubMedCrossRefGoogle Scholar
  168. Khot UM, Novaro GM, Popovic ZB et al. (2003) Nitroprusside in critically ill patients with left ventricular dysfunction and aortic stenosis. N Engl J Med 348: 1756–1763PubMedCrossRefGoogle Scholar
  169. Klinzing S, Simon M, Reinhart K et al. (2003) High-dose vasopressin is not superior to norepinephrine in septic shock. Crit Care Med 31: 2646–2650PubMedGoogle Scholar
  170. Knaus WA, Draper EA, Wagner DP, Zimmermann JE (1985) APACHE II: A severity of disease classification system. Crit Care Med 13: 818–829PubMedGoogle Scholar
  171. König G, Guggenberger M, Bommersbach B (1996) 40jähriger Patient ohne Vorerkrankung mit akuter Schocksymptomatik und schwerer Verbrauchskoagulopathie. Internist 37: 74–77PubMedGoogle Scholar
  172. Konstantinides S, Hasenfuß G (2004) Akutes Cor Pulmonale bei Lungenembolie — Entscheidender prognostischer Faktor und kritischer Parameter für die Auswahl der therapeutischen Strategie. Internist 45: 1155–1162PubMedCrossRefGoogle Scholar
  173. Kontoyannis DA et al. (1999) Mechanical ventilation in conjunction with the intra-aortic ballon pump improves the outcome of patients in profound cardiogenic shock. Intensive Care Med 25: 835–838PubMedCrossRefGoogle Scholar
  174. Köster A, Chew DP, Kuebler W et al. (2003) Effects of tirofiban on hemostatic activation and inflammatory response during cardiopulmonary bypass. Am J Cardiol 91: 346–347PubMedGoogle Scholar
  175. Kovack PJ, Rasak MA, Bates ER et al. (1997) Thrombolysis plus aortic counterpulsation: Improved survival in patients who present to community hospitals with cardiogenic shock. J Am Coll Cardiol 29: 1454–1458PubMedGoogle Scholar
  176. Kreimeier U, Prückner S (1998) Volumentherapie bei Hypovolämie und Schock. Notfall Rettungsmed 1: 119–129CrossRefGoogle Scholar
  177. Kress HG, Scheidewig C, Schmitt H et al. (1999) Reduced incidence of post-operative infections following intravenous application of an IgA-and IgM-enriched immunoglobulin preparation in anergic patients undergoing cardiac surgery. Crit Care Med 27: 1281–1287, 1387-1388PubMedGoogle Scholar
  178. Krishnagopalan S, Kumar A, Parrillo JE, Kumar A (2002) Myocardial dysfunction in the patient with sepsis. Current Opinion Crit Care 8: 376–388Google Scholar
  179. Kuhn C, Müller-Werdan U, Schmitt DV et al. (2000) Improved outcome of APACHE II score-defined escalating systemic inflammatory response syndrome in patients post cardiac surgery in 1996 compared to 1988-1990. Eur J Cardiothorac Surg 17: 30–37PubMedCrossRefGoogle Scholar
  180. Kujath P, Bouchard R, Heinze I et al. (2003) Aktiviertes Protein C, Antithrombin, Heparin und Gewebethromboplastininhibitor: Neue Algorithmen für die Therapie der Sepsis? In: Huhle G (Hrsg) Themenheft: Sepsis und Gerinnung. Intensiv Notfallbehandl 28: 44–54Google Scholar
  181. Kumar A, Parrillo JE ( 2001) Shock: classification, pathophysiology and approach to management. In: Parrillo JE, Dellinger RP (eds) Critical Care Medicine — Principles of diagnosis and management in the adult. Mosby, St. Louis MO, 2nd edn., pp 371–420Google Scholar
  182. Laggner AN (2004) Der Schockpatient auf der Notaufnahme und der Intensivstation. Internist 45: 277–283PubMedCrossRefGoogle Scholar
  183. Lamy M, Nys M, Deby-Dupont G (2001) Reactive nitrogen and oxygen species: role and evidence of their production in humans. In: Vincent JL (ed) 2001 Yearbook of intensive care and emergency medicine. Springer, Berlin Heidelberg New York, pp 284–301Google Scholar
  184. Lefevre N, Delaunay L, Hingot JL, Bonnet F (1996) Bilateral massive adrenal haemorrhage complicating anaphylactic shock: a case report. Intenvive Care Med 22: 447–449Google Scholar
  185. Lehmann D, Radke J, Werdan K (2003) Beatmung beim Herzkranken. In: Werdan K, Trappe HJ, Zerkowski HR (Hrsg) Das Herzbuch — Praktische Herz-Kreislauf-Medizin. Urban & Fischer, München Jena, S. 309–326Google Scholar
  186. Lemery R, Smith HC, Fiuliani ER, Gersh BJ (1992) Prognosis in rupture of the ventricular septum after acute myocardial infarction and role of early surgical intervention. Am J Cardiol 70: 147–151PubMedCrossRefGoogle Scholar
  187. Lesage A et al. (2004) Complicated acute myocardial infarction requiring mechanical ventilation in the intensive care unit: prognostic factors of clinical outcome in series of 157 patients. Crit Care Med 32(1): 100–105PubMedGoogle Scholar
  188. Levy M, Fink MP, Marshall JC et al. for the International Sepsis Definitions Conference (2003) 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definition Conference. Intensive Care Med 29: 530–538 und Crit Care Med 31:1250-1256PubMedGoogle Scholar
  189. Li L, Jacinto R, Yoza B, McCall CE (2003) Distinct post-receptor alterations generate gene-and signal-selective adaptation and cross-adaptation of TLR4 and TLR2 in human leukocytes. J Endotoxin Res 9: 39PubMedCrossRefGoogle Scholar
  190. Liaudet L, Soriano FG, Szabó C (2001) Poly(ADP-Ribose) synthetase as a novel therapeutic target for circulatory shock. In: Vincent JL (ed) 2002 Yearbook of intensive care and emergency medicine. Springer, Berlin Heidelberg New York, pp 78–89Google Scholar
  191. Lincoff AM, Kereiakes DJ, Mascelli MA et al. (2001) Abciximab suppresses the rise in levels of circulating inflammatory markers after percutaneous coronary revascularization. Circulation 104(2): 163–167PubMedGoogle Scholar
  192. Lindenfeld JA (1998) Safety and effectiveness of inhaled nitric oxide and tirofiban for acute coronary syndromes — a report from the Cardiovascular and Renal Advisory Panel of the Food and Drug Administration. Circulation 98: 1829–1830PubMedGoogle Scholar
  193. Lindholm MG, Aldershvile J, Sundgreen C et al. (2003) Effect of early revascularisation in cardiogenic shock complicating acute myocardial infarction. A single center experience. Eur J Heart Failure 5: 73–79CrossRefGoogle Scholar
  194. Lopez A, Lorente JA, Steingrub J et al. (2004) Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: effect on survival in patients with septic shock. Crit Care Med 32: 21–30PubMedGoogle Scholar
  195. Loppnow H (2001) Zytokine: Klassifikation, Rezeptoren, Wirkungsmechanismen. Internist 42: 13–27PubMedCrossRefGoogle Scholar
  196. Lowe PR, Galley HF, Abdel-Fattah A et al. (2003) Influence of interleukin-10 polymorphisms on interleukin-10 expression and survival in critically ill patients. Crit Care Med 31: 34–38PubMedGoogle Scholar
  197. Lu PP, Shee JJ, Chen HM et al. (1999) Spinal nitric oxide participates in the control of the blood pressure during graded hemorrhage in the conscious rat. Shock 12: 222–226PubMedGoogle Scholar
  198. Mailman D, Self A, Henry M (1999) Time-and surgery-dependent effects of lipopolysaccharide on gut, cardiovascular and nitric oxide functions. Shock 12: 208–214PubMedGoogle Scholar
  199. Maisch B, Christ M (2004) Extrakardiale Ursachen der Rechtsherzinsuffizienz. Internist 45: 1136–1146PubMedCrossRefGoogle Scholar
  200. Martin J, Siegenthaler MP, Krause M et al. (2003) Mechanische Kreislaufunterstützung bei akuter und chronischer Herzinsuffizienz — eine Standortbestimmung unter besonderer Berücksichtigung der Entwicklung in Deutschland. Zentralbl Chir 128: 796–803PubMedGoogle Scholar
  201. McDonough KH, Giaimo ME, Miller HI (1995) Effects of endotoxin on the guinea pig heart response to ischemia reperfusion injury. Shock 4: 139–142PubMedGoogle Scholar
  202. Mehta L, Pascual MT, Soroko S (2002) Diuretics, mortality and nonrecovery of renal function in acute renal failure. JAMA 288: 2547–2553PubMedCrossRefGoogle Scholar
  203. Meier-Hellman A, Burgard G (2004) Neue Therapieansätze bei der prähospitalen und hospitalen Schockbehandlung — Hyperton-onkotische Lösungen und Vasopressin. Internist 45: 305–314PubMedCrossRefGoogle Scholar
  204. Melzer C, Gliech A von, Baumann G, Theres H (2001) Severe aortic stenosis and reduced ejection fraction: intensive care treatment. Intensive Care Med 27: 617PubMedCrossRefGoogle Scholar
  205. Menon V, White H, LeJemtel T et al. for the SHOCK Investigators (2000a) The clinical profi le of patients with suspected cardiogenic shock due to predominant left ventricular failure: a report from the SHOCK Trial Registry. J Am Coll Cardiol 36: 1071–1076PubMedGoogle Scholar
  206. Menon V, Webb JG, Hillis LD et al. for the SHOCK Investigators (2000b) Outcome and profile of ventricular septal rupture with cardiogenic shock after myocardial infarction: a report from the SHOCK Trial Registry. J Am Coll Cardiol 36: 1110–1116PubMedGoogle Scholar
  207. Menon V, Slater JN, White HD et al. (2000c) Acute myocardial infarction complicated by systemic hypoperfusion without hypotension: report of the SHOCK Trial Registry. Am J Med 108: 374–380PubMedCrossRefGoogle Scholar
  208. Meyer J, Merx W, Dörr R et al. (1982) Successful treatment of acute myocardial infarction shock by combined percutaneous transluminal coronary recanalization and percutaneous coronary angioplasty. Am Heart J 103: 132–134PubMedCrossRefGoogle Scholar
  209. Michie HR, Manogue KR, Spriggs DR et al. (1988) Detection of circulating tumor necrosis factor after endotoxin administration. N Engl J Med 318: 1481–1486PubMedCrossRefGoogle Scholar
  210. Moerer O, Rossi L de, Roissant R, Burchardi H (2005) Sepsis — Epidemiologie und ökonomische Aspekte. In: Werdan K, Schuster HP, Müller-Werdan U (Hrsg) Intensivtherapie bei Sepsis und MODS, 4. Aufl. Springer, Berlin Heidelberg New YorkGoogle Scholar
  211. Mohr E, Englisch L, Roth A et al. (1997) Effects of early treatment with immunoglobulin on critical illness polyneuropathy following multiple organ failure and gram-negative sepsis. Intensive Care Med 23: 1144–1149PubMedCrossRefGoogle Scholar
  212. Moiseyev VS, Pöder P, Andrejevs N et al. on behalf of RUSSLAN Study Investigators (2002) Safety and efficacy of a novel calcium sensitizer, levosimendan, in patients with left ventricular failure de to an acute myocardial infarction. Eur Heart J 23: 1422–1432PubMedCrossRefGoogle Scholar
  213. Moldawer LL (1999) Organ apoptosis in the septic patient: A potential therapeutic target? Crit Care Med 27: 1381–1382PubMedGoogle Scholar
  214. Moscucci M, Bates ER (1995) Cardiogenic shock. Cardiol Clin 13: 391–406PubMedGoogle Scholar
  215. Moss J, Fahmy NR, Sunder N, Beaven MA (1981) Hormonal and hemodynamic profile of an anaphylactic reaction in man. Circulation 63: 210–213PubMedGoogle Scholar
  216. Motoyama T, Okamoto K, Kukita I et al. (2003) Possible role of increased oxidant stress in multiple organ failure after systemic inflammatory response syndrome: Crit Care Med 31: 1048–1052PubMedGoogle Scholar
  217. Mullan BA, McCloskey BV (2002) Antioxidants and endothelial function. In: Vincent JL (ed) 2002 Yearbook of intensive care and emergency medicine. Springer, Berlin Heidelberg New York, pp 113–120Google Scholar
  218. Mueller HS, Chatterjee K, Davis KB et al. (1998) ACC expert consensus document. Present use of bedside right heart catheterisation in patients with cardiac disease. J Am Coll Cardiol 32: 840–864PubMedCrossRefGoogle Scholar
  219. Müller-Werdan U (2003) Septischer Schock und systemisches Entzündungsreaktions-Syndrom. Dtsch Med Wochenschr 128: 2367–2378PubMedGoogle Scholar
  220. Müller-Werdan U, Werdan K (2000) Anaphylaxie und Allergie — Empfehlungen für die Notfalltherapie. Internist 41: 363–373PubMedGoogle Scholar
  221. Müller-Werdan U, Werdan K (1999) Septic cardiomyopathy. Curr Opin Crit Care 5: 415–420Google Scholar
  222. Müller-Werdan U, Werdan K (2003) Endorganschäden bei Entzündung und Sepsis. Internist 44: 864–871PubMedGoogle Scholar
  223. Müller-Werdan U, Werdan K (2005) Septischer Kreislaufschock und septische Kardiomyopathie. In: Werdan K, Schuster HP, Müller-Werdan U (Hrsg) Intensivtherapie bei Sepsis und MODS, 4. Aufl. Springer, Berlin Heidelberg New YorkGoogle Scholar
  224. Müller-Werdan U, Reithmann C, Werdan K (1996) Cytokines and the heart — molecular mechanisms of septic cardiomyopathy. Landes, Austin USAGoogle Scholar
  225. Müller-Werdan U, Werdan K, Schuster HP (1999) Monitoring von kritisch Kranken mit Sepsis, Multiorgandysfunktionssyndrom und Herz-Kreislauf-Erkrankungen. Intensiv Notfallbeh 24: 10–24Google Scholar
  226. Müller-Werdan U, Buerke M, Werdan K (2003) Fortschritte in der Therapie der Sepsis. Internist 44(12): 1531–1540PubMedGoogle Scholar
  227. Nolan JP, Morley PT, Hoek TL, Hickey RW (2003) Therapeutic hypothermia after cardiac arrest. An advisory statement by the Advancement Life support Task Force of the International Liaison committee on Resuscitation. Resuscitation 57: 231–235PubMedCrossRefGoogle Scholar
  228. O’Brien A, Clapp L, Singer M (2002) Terlipressin for norepinephrine-resistant septic shock. Lancet 359: 1209–1210PubMedGoogle Scholar
  229. Pacht ER, DeMichele SJ, Nelson JL et al. (2003) Enteral nutrition with eicosapentaenoic acid,-linolenic acid, and antioxidants reduces alveolar inflammatory mediators and protein influx in patients with acute respiratory distress syndrome. Crit Care Med 31: 491–500PubMedGoogle Scholar
  230. Papadopoulos MC, Davies DC, Moss RF (2000) Pathophysiology of septic encephalopathy: a review. Crit Care Med 28: 3019–3024PubMedGoogle Scholar
  231. Parkar N, Taylor RW (2001) Adrenal insufficiency in the critically ill patient. In: Parrillo JE, Dellinger RP (eds) Critical care medicine — principles of diagnosis and management in the adult, 2nd edn. Mosby, St. Louis MO, pp 1225–1234Google Scholar
  232. Patel BM, Chittock DR, Russell JA, Walley KR (2002) Beneficial effects of short-term vasopressin infusion during severe septic shock. Anesthesiology 96: 576–582PubMedCrossRefGoogle Scholar
  233. Pfisterer M (2003) Right ventricular involvement in myocardial infarction and cardiogenic shock. Lancet 362: 392–394PubMedCrossRefGoogle Scholar
  234. Plaisance P, Lurie KG, Vicaut E et al. (1999) A comparison of standard cardiopulmonary resucitation and active compression-decompression resuscitation for out-of-hospital cardiac arrest. N Engl J Med 341: 569–575PubMedCrossRefGoogle Scholar
  235. Priori SG, Bossaert LL, Chamberlain DA et al. (2004) ESC-ERC recommendations for the use of automated external defibrillators (AEDs) in Europe. Eur Heart J 25: 437–445PubMedCrossRefGoogle Scholar
  236. Prondzinsky R, Werdan K, Buerke M (2004) Kardiogener Schock: Pathomechanismen, klinischer Verlauf, therapeutische Ansätze und Perspektiven. Internist 45: 284–295PubMedCrossRefGoogle Scholar
  237. Prondzinsky R, Knüfer A, Loppnow H et al. (2005) Surgical trauma affects the proinflammatory status post cardiac surgery to a higher degree than cardiopulmonary bypass. J Thoracic Cardiovasc Surgery (in press)Google Scholar
  238. Pulmonary Artery Consensus Conference Participants (1997) Pulmonary artery consensus conference: Consensus statement. Crit Care Med 25: 910–925Google Scholar
  239. Rao RH, Vagnucci AH, Amico JH (1989) Bilateral massive adrenal hemorrhage: early recognition and treatment. Ann Intern Med 110: 227–235PubMedGoogle Scholar
  240. Raper RF, Fisher MMD (1988) Profound reversible myocardial depression after anaphylaxis. Lancet I: 386–388Google Scholar
  241. Raper R, Sibbald WJ, Driedger AA, Gerow K (1989) Relative myocardial depression in normotensive sepsis. J Crit Care 4: 9–18CrossRefGoogle Scholar
  242. Raper RF, Sibbald WJ (1988) The effects of coronary artery disease on cardiac function in nonhypotensive sepsis. Chest 94: 507–511PubMedGoogle Scholar
  243. Rauchhaus M, Müller-Werdan U (2001) Zytokine bei Herzerkrankungen. Internist 42: 75–84PubMedCrossRefGoogle Scholar
  244. Read RC, Wyllie DH (2001) Toll receptors and sepsis. Curr Opin Crit Care 7: 371–375PubMedGoogle Scholar
  245. Redl G, Germann P, Plattner H, Hammerle A (1993) Right ventricular function in early septic shock states. Intensive Care Med 19: 3–7PubMedCrossRefGoogle Scholar
  246. Redling F, Neumann I, Zerkowski H-R (1998) Herzverletzungen. Intensiv Notfallbeh 23: 85–95Google Scholar
  247. Reinhart K, Meier-Hellmann A, Beale R et al. (2004) Open randomized phase II trial of an extracorporeal endotoxin absorber in suspected gram-negative sepsis. Crit Care Med 32: 1662–1668PubMedGoogle Scholar
  248. Reithmann C, Hallström S, Pilz G et al. (1993) Desensitization of rat cardiomyocyte adenyl cyclase stimulation by plasma of noradrenalinetreated patients with septic shock. Circ Shock 41: 48–59PubMedGoogle Scholar
  249. Riess H (1998) Hämostasestörungen im Umfeld von Sepsis und SIRS. Internist 39: 479–484PubMedCrossRefGoogle Scholar
  250. Rinne T, Zwissler B (2004) Intraoperatives anästhesiologisches Management bei Patienten mit pulmonaler Hypertonie. Intensiv Notfallbehandl 29: 4–13Google Scholar
  251. Rivers, E., Nguyen, B., Havstad et al. for the Early Goal-Directed Therapy Collaborative Group (2001) Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 345: 1368–1377 (Editorial: Evans TW. Hemodynamic and metabolic therapy in critically ill patients. 345:1417-1418)PubMedCrossRefGoogle Scholar
  252. Ruß M, Seige M, Werdan K (2005) Allgemeine Intensivtherapie. In: Paumgartner G (Hrsg) Therapie innerer Krankheiten, 11. Aufl. Springer, Berlin Heidelberg New York (im Druck)Google Scholar
  253. Ryan TJ (1999) Early revascularization in cardiogenic shock — a positive view of a negative trial. N Engl J Med 341: 687–688PubMedCrossRefGoogle Scholar
  254. Sablotzki A, Dehne MG, Prondzinsky R et al. (2000) Management von Notfallsituationen im Krankenhaus. Intensiv Notfallbehandl 25: 152–160Google Scholar
  255. SAFE Study Investigators (2004) A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med 350: 2247–2256 (Editorial: Cook D (2004) Is Albumin Safe? 350:2294-2296 )Google Scholar
  256. Samtleben W, Bengsch S, Boos KS et al. (1998) HELP apheresis in the treatment of sepsis. Artif Organs 22: 43–46PubMedCrossRefGoogle Scholar
  257. Sanborn TA, Sleeper LA, Bates ER et al. (2000) Impact of thrombolysis, intra-aortic balloon pump counterpulsation, and their combination in cardiogenic shock complicating acute myocardial infarction: a report from the SHOCK Trial Registry. Should we emergently revascularize occluded coronaries for cardiogenic shock? J Am Coll Cardiol 36(Suppl A): 1123–1129PubMedGoogle Scholar
  258. Schlag G, Redl H (eds) (1993) Pathophysiology of shock, sepsis and organfailure. Springer, Berlin Heidelberg New YorkGoogle Scholar
  259. Schmidt H, Müller-Werdan U (2003) Warum sollte der Intensivmediziner der autonomen Dysfunktion seiner Patienten Beachtung schenken? Intensiv Notfallbehandl 28: 137–146Google Scholar
  260. Schmidt W, Nottrott M, Desel H (1998) Lebensbedrohliche akute Intoxikationen durch kardio-und vasotoxisch wirkende Medikamente und Drogen. Intensiv Notfallbeh 23: 27–49Google Scholar
  261. Schmidt H, Werdan K, Müller-Werdan U (2001) Autonomic function in the ICU patient. Curr Opinion Crit Care 7: 314–322Google Scholar
  262. Scholz KH, Figulla HR, Schröder T et al. (1995) Pulmonary and left ventricular decompression by artificial pulmonary valve incompetence during percutaneous cardiopulmonary bypass support in cardiac arrest. Circulation 91: 2664–2668PubMedGoogle Scholar
  263. Schuster HP, Schuster FP, Ritschel P et al. (1997) The ability of the simplified acute physiology score (SAPS II) to predict outcome in coronary care patients. Intens Care Med 23: 381–384Google Scholar
  264. Schwertz H, Müller-Werdan U, Prondzinsky R et al. (2004) Katecholamine im kardiogenen Schock: hilfreich, nutzlos oder gefährlich? Dt Med Wochenschr 129: 1925–1930Google Scholar
  265. Seige M, Werdan K, Prondzinsky R (2001) Beatmung bei Herzkranken. Intensivmed 38: 299–313CrossRefGoogle Scholar
  266. Seyfarth M, Schömig A (2004) Die rechtsventrikuläre Beteiligung beim akuten Myokardinfarkt. Internist 45: 1117–1124PubMedCrossRefGoogle Scholar
  267. Shapiro MJ (2001) Traumatic shock: nonsurgical management. In: Parrillo JE, Dellinger RP (eds) Critical care medicine — principles of diagnosis and management in the adult, 2nd edn. Mosby, St. Louis MO, pp 501–512Google Scholar
  268. Shapiro NI, Wolfe RE, Moore RB et al. (1996) Mortality in emergency department sepsis (MEDS) score: a prospectively derived and validated clinical prediction rule. Crit Care Med 31: 670–675Google Scholar
  269. Shehata N, Kouroukis C, Kelton JG (2002) A review of randomized controlled trials using therapeutic apheresis. Transfus Med Rev 16: 200–229PubMedCrossRefGoogle Scholar
  270. Silver MA, Horton DP, Ghali JK, Elkayam U (2002) Effect of nesiritide versus dobutamine on short-term outcomes in the treatment of patients with acutely decompensated heart failure. J Am Coll Cardiol 39: 798–803PubMedCrossRefGoogle Scholar
  271. Silverman HJ, Penaranda R, Orens JB, Lee NH (1993) Impaired β-adrenergic receptor stimulation of cyclic adenosine monophosphate in human septic shock: association with myocardial hyporesponsiveness to catecholamines. Crit Care Med 21: 31–39PubMedGoogle Scholar
  272. Silverman HJ, Van Hook C, Haponik EF (1984) Hemodynamic changes in human anaphylaxis. Am J Med 77: 341–343PubMedCrossRefGoogle Scholar
  273. Simon TL, Alverson DC, AuBuchon J et al. (1998) Practice parameter for the use of red blood cell transfusions — developed by the red blood cell administration practice guidelines development task force fo the College of American Pathologists. Arch Pathol Lab Med 122: 130–138PubMedGoogle Scholar
  274. Slater J, Brown RJ, Antonelli TA et al. for the SHOCK Investigators (2000) Cardiogenic shock due to cardiac free-wall rupture or tamponade after acute myocardial infarction: a report from the SHOCK Trial Registry. J Am Coll Cardiol 36: 1117–1122PubMedCrossRefGoogle Scholar
  275. Song W, Furman BL, Parratt JR (1994) Attenuation by dexamethasone of endotoxin protection against ischaemia-induced ventricular arrhythmias. Br J Pharmacol 113: 1083–1084PubMedGoogle Scholar
  276. Spies C, Haude V, Fitzner R et al. (1998) Serum cardiac troponin T as a prognostic marker in early sepsis. Chest 113: 1055–1063PubMedGoogle Scholar
  277. Stacpoole PW, Wright EC, Baumgartner TG et al. (1992) A controlled trial of dichloroacetate for treatment of lactic acidosis in adults. N Engl J Med 327: 1564–1569PubMedCrossRefGoogle Scholar
  278. Stallmach A, Zeitz M (1998) Der Darm als immunologisches Organ. Wien Klin Wochenschr 110: 72–78PubMedGoogle Scholar
  279. Stegmayr BG (2001) Apheresis as therapy for patients with severe sepsis and multiorgan dysfunction syndrome. Therapeutic Apheresis 5: 123–127PubMedGoogle Scholar
  280. Stegmayr BG, Banga R, Berggren L et al. (2003) Plasma exchange as rescue therapy in multiple organ failure ncluding acute renal failure. Crit Care Med 31: 1730–1736PubMedGoogle Scholar
  281. Stomel RJ, Rasak M, Bates ER (1994) Treatment strategies for acute myocardial infarction complicated by cardiogenic shock in a community hospital. Chest 105: 997–1002PubMedGoogle Scholar
  282. Suchner U (2002) Enterale Immunonutrition: wann, für wen, welche Zukunftsperspektiven gibt es? Aktuel Ernaehr Med 27: 205–215CrossRefGoogle Scholar
  283. Suffredini AF, Fromm RE, Parker MM et al. (1989) The cardiovascular response of normal humans to the administration of endotoxin. N Engl J Med 321: 280–287PubMedCrossRefGoogle Scholar
  284. Sullivan TJ (1982) Cardiac disorders in penicillin-induced anaphylaxis. JAMA 248: 2161–2162PubMedCrossRefGoogle Scholar
  285. Sun Q, Dimopoulos G, Nguyen DN et al. (2003) Low-dose vasopressin in the treatment of septic shock in sheep. Am J Respir Crit Care Med 168: 481–486PubMedCrossRefGoogle Scholar
  286. Szabó C, Liaudet L (2002) Myocardial ischemia-reperfusion injury: role of the peroxynitrite-poly(ADP-ribose) polymerase pathway. In: Vincent JL (ed) 2002 Yearbook of intensive care and emergency medicine. Springer, Berlin Heidelberg New York, pp 165–176Google Scholar
  287. Taniguchi T, Koido y, Aiboshi J et al. (1999) Change in the ratio of interleukin-6 to interleukin-10 predicts a poor outcome in patients with systemic inflammatory response syndrome. Crit Care Med 27: 1262–1264PubMedGoogle Scholar
  288. Task Force of the American College of Critical Care Medicine, Society of Critical Care Medicine (1999) Practice parameters for hemodynamic support of sepsis in adult patients in sepsis. Crit Care Med 27: 639–660Google Scholar
  289. Tcheng JE, Jackman JD, Nelson CL et al. (1992) Outcome of patients sustaining acute ischemic mitral regurgitation during myocardial infarction. Ann Intern Med 117: 18–24PubMedGoogle Scholar
  290. Thackray S, Easthaugh J, Freemantle N, Cleland JGF (2002) The effectivenes and relative effectiveness of intravenous inotropic drugs acting through the adrenergic pathway in patients with heart failure — a meta-regression analysis. Eur Heart Fail 4: 515–529Google Scholar
  291. Thiele H, Lauer L, Hambrecht R et al. (2001) Reversal of cardiogenic shock by percutaneuos left atrial to femoral artrial bypass-systems. Circulation 104: 2917–2922PubMedGoogle Scholar
  292. Thiele H, Lauer B, Hambrecht R et al. (2003) Short-and long-term hemodynamic effects of intra-aortic balloon support in ventricular septal defect complicating acute myocardial infarction. Am J Cardiol 92: 450–454PubMedCrossRefGoogle Scholar
  293. Thiemermann C (1995) Inhibition of nitric oxide synthase activity in circulatory shock: friend or foe? In: Fink MP, Payen D (eds) Role of nitric oxide in sepsis and ARDS (update in intensive care and emergency medicine 24). Springer, Berlin Heidelberg New York, pp 201–216Google Scholar
  294. Thiemermann C (2000a) Globale und regionale Zirkulationsstörungen bei Sepsis. In: Burchardi H, Briegel J, Eckart J et al. (Hrsg) Expertenforum: Hämodynamisch aktive Substanzen in der Intensivmedizin. Anästhesiol Intensivmed 41: 585–592Google Scholar
  295. Thiemermann C (2000b) NOS-Inhibitoren. In: Burchardi H, Briegel J, Eckart J et al. (Hrsg) Expertenforum: Hämodynamisch aktive Substanzen in der Intensivmedizin. Anästhesiol Intensivmed 41: 614–615Google Scholar
  296. Thompson CR, Buler CE, Sleeper LA et al. for the SHOCK Investigators (2000) Cardiogenic shock due to acute severe mitral regurgitation complicating acute myocardial infarction: a report from the SHOCK Trial Registry. J Am Coll Cardiol 36: 1104–1109PubMedGoogle Scholar
  297. Tsegai E, Schütze B, Gläser F et al. (2004) Nephritis epidemica auf einer interdisziplinären Notaufnahme — Fallsammlung im Rahmen einer Endemie-Erfassung der Ostalbregion und Literaturübersicht. Intensiv Notfallbehandl 29: 3Google Scholar
  298. Tsuneyoshi I, Yamada H, Kakihana Y et al. (2001) Hemodynamic and metabolic effects of low-dose vasopressin infusions in vasodilatory septic shock. Crit Care Med 29: 487–493PubMedGoogle Scholar
  299. Tulleken JE, Fijen JW, Zijlstra JG (2001) Inhibition of 38 mitogen activated protein kinase: a novel strategy in sepsis? In: Vincent JL (ed) 2001 Yearbook of intensive care and emergency medicine. Springer, Berlin Heidelberg New York, pp 90–99Google Scholar
  300. Van den Berghe G, Wouters P, Weekers F et al. (2001) Intensive insulin therapy in critically ill patients. N Engl J Med 345: 1359–1367 (Editorial: Evans TW. Hemodynamic and metabolic therapy in critically ill patients. 345: 1417-1418)PubMedGoogle Scholar
  301. Van den Berghe G, Wouters PJ, Bouillon R et al. (2003) Outcome benefit of intensive insulin therapy in the critically ill: insulin dose versus glycemic control. Crit Care Med 31: 359–366PubMedGoogle Scholar
  302. Vincent JL, Moreno R, Takala J et al. on behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine (1996) The SOFA (sepsis-related organ failure assessment) score to describe organ dysfunction. Intensive Care Med 22:707–710PubMedGoogle Scholar
  303. Visvanathan K, Zabriskie JB (2000) The role of bacterial superantigens in sepsis and treatment implications. Curr Opin Crit Care 6: 312–316Google Scholar
  304. Walther A, Böttiger BW (2004) Anaphylaktoide Reaktionen in der Prähospitalphase. Internist 45: 296–304PubMedCrossRefGoogle Scholar
  305. Wang P, Hauptman JG, Chaudry IH (1990) Hemorrhage produces depression in microvascular blood flow which persists despite fluid resuscitation. Circ Shock 32: 307–318PubMedGoogle Scholar
  306. Weil MH, Nakagawa Y, Tang W et al. (1999) Sublingual capnometry: a new noninvasive measurement for diagnosis and quantitation of severity of circulatory shock. Crit Care Med 27: 1225–1229PubMedGoogle Scholar
  307. Wenzel V, Krismer AC, Arntz HR et al. (2004) A comparison of vasopressin and epinephrine for out-of-hospital cardiopulmonary resuscitation. N Engl J Med 350: 105–113PubMedCrossRefGoogle Scholar
  308. Werdan K (2000) Septische Kardiomyopathie. In: Burchardi H, Briegel J, Eckart J et al. (Hrsg) Expertenforum: Hämodynamisch aktive Substanzen in der Intensivmedizin. Anästhesiol Intensivmed 41: 594–599Google Scholar
  309. Werdan K (2001a) Mechanische und elektrische Therapie kardialer Arrhythmien. In: Van Aken H, Reinhart K, Zimpfer M (Hrsg) Intensivmedizin. Thieme, Stuttgart New York, 176–188Google Scholar
  310. Werdan K (2001b) Assessment of IVIG for prophylaxis and therapy of sepsis. Curr Opin Crit Care 7: 354–361PubMedGoogle Scholar
  311. Werdan K, Boekstegers P, Müller U et al. (1991) Akute septische Kardiomyopathie: Bestandteil des Multiorganversagens in der Sepsis? Med Klin 86: 526–534Google Scholar
  312. Werdan K, Schuster HP, Müller-Werdan U (Hrsg) (2005) Intensivtherapie bei Sepsis und MODS, 4. Aufl. Springer, Berlin Heidelberg New YorkGoogle Scholar
  313. Witthaut R, Busch C, Fraunberger P et al. (2003) Plasma atrial natriuretic peptide and brain natriuretic peptide are increased in septic shock: impact of interleukin-6 and sepsis-associated left ventricular dysfunction. Intensive Care Med 29: 1696–1702PubMedCrossRefGoogle Scholar
  314. Yao Z, Auchampach JA, Pieper GM, Gross GJ (1993) Cardioprotective effects of monophosphoryl lipid A, a novel endotoxin analogue in the dog. Cardiovasc Res 27: 832–838PubMedCrossRefGoogle Scholar
  315. Yocum MW, Butterfield JH, Klein JS et al. (1999) Epidemiology of anaphylaxis in Olmsted county: a population — based study. J Allergy Clin Immunol 104: 452–456PubMedCrossRefGoogle Scholar
  316. Zahn R, Fraiture B, Siegler KE et al. (2003) Effectiveness of the glycoprotein IIb/IIIa antagonist abciximab during percutaneous coronary interventions (PCI) in clinical practice at a single high-volume center. Z Kardiol 92: 438–444PubMedCrossRefGoogle Scholar
  317. Zauner C, Genod A, Kramer L et al. (2000) Metabolic encephalopathy in critically ill patients suffering from septic or nonseptic multiple organ failure. Crit Care Med 28: 1310–1315PubMedGoogle Scholar
  318. Zehender M, Kasper W, Kauder E et al. (1993) Right ventricuar infarction as an independent predictor of prognosis after acute inferior myocardial infarction. N Engl J Med 328: 981–988PubMedCrossRefGoogle Scholar
  319. Zell R, Geck P, Werdan K, Boekstegers P (1997) TNF-a and IL-1a inhibit both pyruvate dehydrogenase activity and mitochondrial function in cardiomyocytes: evidence for primary impairment of mitochondrial function. Mol Cell Biochem 177: 61–67PubMedCrossRefGoogle Scholar
  320. Zeymer U, Tebbe U, Weber M et al. (2003) Prospective evaluation of early abciximab and primary percutaneous intervention for patients with ST elevation myocardial infarction complicated by cardiogenic shock: results of the REO-SHOCK Trial. J Invasive Cardiol 15: 385–389PubMedGoogle Scholar
  321. Zeymer U, Vogt A, Zahn R for the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausärzte (2004) Predictors of in-hospital mortality in 1333 patients with acute myocardial infarction complicated by cardiogenic shock treated with primary percutaneous coronary intervention (PCI) — Results of the primary PCI registry of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausärzte (ALKK). Eur Heart J 25: 322–328PubMedCrossRefGoogle Scholar
  322. Zonghai H, Han G, Renbao X (2002) Study on glucocorticoid receptors during intestinal ischemia shock and septic shock. Circ Res 23: 27–36Google Scholar
  323. Zotz RJ, Dohmen G, Genth S, Erbel R, Meyer J (1993) Diagnosis of papillary muscle rupture after acute myocardial infarction by transthoracic and transesophageal echocardiography. Clin Cardiol 16: 665–670PubMedCrossRefGoogle Scholar
  324. Zweier JL, Wang P, Samouilov A, Kuppusami P (1995) Enzyme-independent formation of nitric oxide in biological tissues. Nature Med 1: 804–809; letter to the editor: 1103PubMedGoogle Scholar

Copyright information

© Springer Medizin Verlag Heidelberg 2006

Authors and Affiliations

  • U. Müller-Werdan
    • 1
  • M. Buerke
    • 1
  • A. Christoph
    • 1
  • R.R. Flieger
    • 1
  • H. Loppnow
    • 1
  • R. Prondzinsky
    • 2
  • S. Reith
    • 1
  • H. Schmidt
    • 1
  • K. Werdan
    • 3
  1. 1.Universitätsklinik und Poliklinik für Innere Medizin IIIMartin-Luther-UniversitätHalleGermany
  2. 2.Medizinische Klinik ICarl-von Basedow-Klinikum MerseburgMerseburgGermany
  3. 3.Universitätsklinik und Poliklinik für Innere Medizin IIIMartin-Luther-UniversitätHalleGermany

Personalised recommendations